Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy
In our most recent article, in Molecular Imaging, we explore the potential to use Near Infrared Optical Imaging as a biomarker to assess muscle pathology secondary to disease processes, specifically two variants of muscular dystrophy. As these diseases are progressive by nature, it is important to be able assess progression of disease. With the rapid pipeline of treatments reaching clinical trials, it was equally important to be able to assess mitigation of disease. Overall, we demonstrate the ability to utilize this technology to further assess worsening and reversal of muscle pathology in two disease states.
I'm a current MD-PhD candidate, working hard to help treat and manage muscular dystrophies